Confirmed Exhibitors

3p Biovian

Abioinnova

Albian

Asphalion

ASPHALION is an international Regulatory, Scientific & Safety consultancy company with offices in Barcelona, Madrid, Munich, London, and Pamplona. Since its foundation in 2000, ASPHALION has grown consistently to employ over 190 professionals representing more than 16 nationalities. Its strong track record has established ASPHALION as a key player in the international healthcare sector and a major contributor to the implementation of new regulatory standards.
ASPHALION provides expert consulting, strategic advice, operational support, and full outsourcing services for all product life cycle stages across all therapeutic areas. Its team offers tailored solutions for Pharmaceutical, Biotechnological, and Medical Technology companies, having successfully delivered over 5,000 projects for more than 1,000 clients from over 50 countries. Services span non-clinical and clinical development, CMC, dossier writing, regulatory procedures, vigilance, eSubmissions, and data management for both medicinal products and medical devices.
The company’s expertise is particularly notable in the field of Advanced Therapy Medicinal Products (ATMPs), where their team possesses specialized scientific knowledge and extensive regulatory experience. ATMPs require unique development strategies and regulatory adaptations due to their complexity. ASPHALION provides comprehensive support, including drafting regulatory, non-clinical, clinical, and CMC documentation essential for development, registration, and lifecycle management. Additionally, they offer strategic guidance on segmentation, niche indications, conditional approvals, fast-track processes, orphan drug designations, and preclinical and clinical development plans to minimize time-to-market.
ASPHALION has been a leader in ATMP regulatory support since 2005, participating in over 30 projects covering cell therapy (autologous and allogenic derived stem cells, CAR-T) and gene therapy (oncolytic viruses, adeno-associated virus (AAV), Modified Vaccinia Virus (MVA), Plasmids, Lentivirus, Adenovirus (AdV), and more). By collaborating closely with international competent authorities, notified bodies, scientific associations, and key opinion leaders, ASPHALION ensures the delivery of optimal solutions for every project. Their comprehensive network of geographic and functional partners further solidifies their ability to meet the needs of a dynamic and evolving healthcare landscape.

Charles River

Charles River is a leading global CRO supporting biotech and pharmaceutical companies across the entire early drug‑development continuum. We provide research models, discovery and safety assessment services, and manufacturing and biologics testing solutions, enabling clients to accelerate preclinical research and advance therapies toward the clinic.

Charles River has supported work on over 80% of FDA‑approved drugs in the past five years and offers an integrated portfolio spanning in vitro and in vivo studies, toxicology, pharmacology, cell and gene therapy support, and microbial testing. With operations in 20+ countries and recognized expertise built since its founding in 1947, we serve as a critical partner helping biotech innovators de‑risk and streamline the development of novel therapeutics.

Curapath

Curapath is a CDMO specializing in novel drug delivery systems (DDS) with expertise in LNP and PNP formulation and GMP manufacturing. We support the entire therapeutic journey, from development to Commercial, providing GMP manufacturing for Drug Substance and Drug Product. With unmatched technical and analytical expertise, we design, develop, and manufacture polymer- and lipid-based DDS for cell therapy, gene therapy, and vaccines. For over a decade, we’ve supported innovators with excipients, polymers, and linkers, accelerating drug development with hands-on guidance and scalable solutions

IVACE

IVACE is a public body depending on the Regional Ministry of Innovation, Industry, Commerce and Tourism from the Region of Valencia. In IVACE Internacional we support companies on their paths to internationalisation. Thanks to our broad network of delegations in 35 markets we can offer tailored services to help the companies find distribution channels abroad and we are also experts in organising international fairs and trade missions to foster their worldwide relationships. Among all the exporting sectors in the Region of Valencia, biotechnology stands out as one of the most dynamic and competitive, and IVACE International works also in fostering their international presence.

Jori Armengol

JORI& – Strategic Risk & Insurance Consulting Since 1890

JORI& is an independent insurance brokerage and risk consulting firm founded in 1890, with a long-standing tradition of advising companies through complex and evolving risk environments.

We specialize in providing tailored insurance and risk management solutions to innovative and high-growth sectors, including Life Sciences, Biotechnology, MedTech, Digital Health, and DeepTech.

Our approach goes beyond traditional insurance placement. We work as strategic partners to founders, CEOs, CFOs, and boards, helping them identify, assess, and transfer critical risks across every stage of growth — from early R&D and clinical trials to international expansion and scaling.

Our expertise includes:

Clinical Trials Insurance (local & multinational programs)

Product Liability & Professional Liability

Directors & Officers (D&O) coverage

Cyber Risk & Data Protection

Intellectual Property risk solutions

Property & Operational risk programs

International insurance structuring

As active partners within innovation ecosystems, we collaborate with research institutions, biotech hubs, investors, and industry associations to support sustainable and secure growth.

At JORI&, we believe insurance is not just protection — it is a strategic tool that enables innovation, investment, and long-term progress.

You make your decisions. We secure your progress.

We look forward to connecting with fellow innovators at BioSpain 2026.

Klinea

Klinea especializada en ingeniería de procesos para la industria Biotech y Farma, ofreciendo soluciones sólidas y a medida. Destaca por su liderazgo en optimización de la producción bajo normativas GMP y FDA, y por impulsar la digitalización con auditorías y planes estratégicos. Integra la sostenibilidad como pilar clave, desarrollando soluciones eficientes y responsables para el futuro del sector.

Leanbio

Leanbio is a cutting-edge CDMO specializing in bioconjugation and complex biologics, including recombinant proteins, antibodies, and mRNA. With both microbial and mammalian production platforms, Leanbio delivers seamless, end-to-end biopharmaceutical development and GMP manufacturing services.

The company provides tailored cell line and process development solutions, supporting programs from standard monoclonal antibodies to complex and novel biologics, including ADCs.

SID

Wuxi AppTec

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time.

Zendal

CZ Vaccines belongs to the ZENDAL biopharmaceutical group, which brings together various companies focused on the research, development, manufacturing, and marketing of high value-added biological and pharmaceutical products in the healthcare industry, for both human and animal health.

Our human and animal CDMO services are now unified under the ZENDAL name, so you can find us under the name ZENDAL rather than CZ Vaccines, to better focus on our CDMO services https://www.zendal.com/

ZENDAL is an ideal partner for any organization wishing to advance the development of its biological product candidates, from the development phase to clinical phases I to III, and commercial supply capacity.

We have cutting-edge technology, with solid technical, development, and manufacturing capabilities in VACCINES and THERAPEUTICS.

ZENDAL also contributed to the urgent development of solutions against COVID-19 through our research and manufacturing capabilities.

Your partner for BIOLOGICS manufacturing:

• Live & Inactivated Bacteria & Viral Vaccines up to BSL-2

• Sterile processing systems

• Process Development / Optimisation (Upstream / Downstream)

• Scale-up and cGMP manufacturing

• Aseptic filling into vials

• Lyophilization (clinical trial material and large scale)

• Quality control testing: Microbiological: Sterility-non-sterility, Chemical-Physical and Biological

• Labeling & packaging

• DS & DP release

• Storage: (+2-8ºC), (-30ºC), (-80ºC)

ZBM Patents & Trademarks

ZBM is a firm based on quality and transparency founded at the end of 2003 with the clear objective of helping to change the patent landscape in Spain. More than two decades later, ZBM is proud to have contributed to setting a new standard of quality in patent practice. With this same objective in mind, ZBM staff regularly participate in academic activities to help improve the quality of patent and trademark practitioners in Spain, including those working in other patent firms.
ZBM specialises in the biomedical field, with a completely wide-field view of the sector, our experts having extensive cross-cutting competencies. We work on everything from identifying inventions and protecting them in the broadest possible way, including patents, trade secrets and copyright, following through to conducting freedom-to-operate studies and providing support in any technology transfer process. This comprehensive knowledge of the sector has allowed us to approach venture capital firms, and we regularly carry out due diligence for them in relation to their potential investments.
In short, we are not only familiar with the patent system, but also with the biomedical field itself, including issues such as investment and regulation, this allows us to offer the best personalised service to our clients.